Kevin P. Kerns

Array ( [id] => 11364092 [patent_doc_number] => 20170002073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-01-05 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 15/039524 [patent_app_country] => US [patent_app_date] => 2014-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 36290 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15039524 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13165779 [patent_doc_number] => 10098982 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-10-16 [patent_title] => Compositions and methods for macrophage conversion [patent_app_type] => utility [patent_app_number] => 15/036822 [patent_app_country] => US [patent_app_date] => 2014-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 24 [patent_no_of_words] => 12297 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15036822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11092359 [patent_doc_number] => 20160289328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-06 [patent_title] => 'MONOVALENT ANTIGEN BINDING CONSTRUCTS TARGETING EGFR AND/OR HER2 AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 15/036174 [patent_app_country] => US [patent_app_date] => 2014-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 45705 [patent_no_of_claims] => 112 [patent_no_of_ind_claims] => 70 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15036174 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11499231 [patent_doc_number] => 20170073415 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-16 [patent_title] => 'NOVEL MULTISPECIFIC MOLECULES AND NOVEL TREATMENT METHODS BASED ON SUCH MULTISPECIFIC MOLECULES' [patent_app_type] => utility [patent_app_number] => 15/310420 [patent_app_country] => US [patent_app_date] => 2014-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 25259 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15310420 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11350247 [patent_doc_number] => 20160368987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-22 [patent_title] => 'BISPECIFIC CONSTRUCTS AND THEIR USE IN THE TREATMENT OF VARIOUS DISEASES' [patent_app_type] => utility [patent_app_number] => 15/031576 [patent_app_country] => US [patent_app_date] => 2014-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13554 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15031576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11107601 [patent_doc_number] => 20160304572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-20 [patent_title] => 'PRODUCTION OF RECOMBINANT LUBRICIN' [patent_app_type] => utility [patent_app_number] => 15/030825 [patent_app_country] => US [patent_app_date] => 2014-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11159 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15030825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11054444 [patent_doc_number] => 20160251406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-01 [patent_title] => 'HLA-A24 AGONIST EPITOPES OF MUC1-C ONCOPROTEIN AND COMPOSITIONS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 15/031435 [patent_app_country] => US [patent_app_date] => 2014-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26841 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15031435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9838527 [patent_doc_number] => 20150030608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-29 [patent_title] => 'Method of Treating Crohn\'s Disease By Administering An Anti-IL-12 Antibody' [patent_app_type] => utility [patent_app_number] => 14/512757 [patent_app_country] => US [patent_app_date] => 2014-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 39813 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14512757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10201520 [patent_doc_number] => 20150086508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-26 [patent_title] => 'COMPOSITIONS AND METHODS FOR ENHANCING EPIDERMAL REPAIR AND CUTANEOUS INNATE IMMUNITY' [patent_app_type] => utility [patent_app_number] => 14/500373 [patent_app_country] => US [patent_app_date] => 2014-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 16300 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14500373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9857314 [patent_doc_number] => 20150037331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-05 [patent_title] => 'IL-31 MONOCLONAL ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/498058 [patent_app_country] => US [patent_app_date] => 2014-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 55315 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14498058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9798613 [patent_doc_number] => 20150010557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-08 [patent_title] => 'Propylene Glycol Compositions for Intranasal Administration of Active Agents to the Central Nervous System' [patent_app_type] => utility [patent_app_number] => 14/495291 [patent_app_country] => US [patent_app_date] => 2014-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17036 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14495291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11048837 [patent_doc_number] => 20160245795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-08-25 [patent_title] => 'METHOD FOR EVALUATING THE HARMFUL EFFECTS OF UV ON CHILDREN\'S SKIN' [patent_app_type] => utility [patent_app_number] => 15/023882 [patent_app_country] => US [patent_app_date] => 2014-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14714 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15023882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9798610 [patent_doc_number] => 20150010554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-08 [patent_title] => 'METHODS FOR TREATING INTERLEUKIN-6 RELATED DISEASES' [patent_app_type] => utility [patent_app_number] => 14/495001 [patent_app_country] => US [patent_app_date] => 2014-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12049 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14495001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16500012 [patent_doc_number] => 10865388 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-15 [patent_title] => Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemness [patent_app_type] => utility [patent_app_number] => 15/513804 [patent_app_country] => US [patent_app_date] => 2014-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 17 [patent_no_of_words] => 18169 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15513804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11107603 [patent_doc_number] => 20160304574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-10-20 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES AND DISORDERS' [patent_app_type] => utility [patent_app_number] => 15/026927 [patent_app_country] => US [patent_app_date] => 2014-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 32447 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15026927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10202830 [patent_doc_number] => 20150087818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-26 [patent_title] => 'CHIMERIC IL-1 RECEPTOR TYPE I AGONISTS AND ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 14/460563 [patent_app_country] => US [patent_app_date] => 2014-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 37781 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14460563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9857262 [patent_doc_number] => 20150037279 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-05 [patent_title] => 'SUSTAINED RELEASE FORMULATION OF INTERLEUKIN-10 FOR WOUND TREATMENT AND RELATED METHODS' [patent_app_type] => utility [patent_app_number] => 14/449657 [patent_app_country] => US [patent_app_date] => 2014-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19352 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14449657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11914300 [patent_doc_number] => 09782475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-10 [patent_title] => 'Method of treating food allergies by administering a nanoparticle comprising heparin and chitosan encapsulating IL-12' [patent_app_type] => utility [patent_app_number] => 14/336411 [patent_app_country] => US [patent_app_date] => 2014-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 25 [patent_no_of_words] => 16789 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14336411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11930891 [patent_doc_number] => 09797882 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-24 [patent_title] => 'Method of screening for a compound for inhibitory activity of FN14-tweak interaction' [patent_app_type] => utility [patent_app_number] => 14/904363 [patent_app_country] => US [patent_app_date] => 2014-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 28 [patent_no_of_words] => 29778 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 185 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14904363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11521676 [patent_doc_number] => 09605062 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-28 [patent_title] => 'Polynucleotides encoding ZCYTOR17 ligand antibodies' [patent_app_type] => utility [patent_app_number] => 14/296488 [patent_app_country] => US [patent_app_date] => 2014-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 80535 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14296488 [rel_patent_id] =>[rel_patent_doc_number] =>)